Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

‘My pharmacies could be unviable if I have to repay advance funding’

Thousands of pharmacies will be forced to close if they have to repay advance funding to the government, including his own, says one contractor.

The advance funding of £300 million from the government to alleviate cash flow issues caused by COVID-19 will need to be repaid at a later date.

But Olivier Picard, owner of three-strong Newdays Pharmacy group in Berkshire, says his business is among thousands who will be unable to afford to stay open when this money is clawed back.

The tens of thousands of pounds he is paying to keep his business afloat during the pandemic are already “crippling”, says Mr Picard, who is a National Pharmacy Association board member.

Listen to the podcast to hear more about:

  • Sourcing personal protective equipment (PPE) at any expense after NHS England supplies ran out
  • Worsening medicines pricing problems, culminating in one wholesaler asking for almost double the concessionary price of sertraline
  • How pharmacy has demonstrated the value of every store during the pandemic

You can listen to the podcast below. Alternatively, subscribe to C+D's podcasts on iTunes or by searching “Chemist+Druggist podcast” on your preferred Android podcast app.

Please note, the sound quality of this podcast may be affected as it has been recorded remotely during the COVID-19 outbreak

To keep up with the latest updates for community pharmacy visit our COVID-19 hub.

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD005198

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel